Plain-English translation of NCT01209000 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that follows patients diagnosed with rare kidney diseases—specifically minimal change disease, membranous nephropathy, and focal segmental glomerulosclerosis—to better understand why these conditions behave so differently from person to person. Researchers will collect medical information, blood samples, and tissue samples from kidney biopsies to identify the underlying biological reasons for these differences. The goal is to help doctors eventually tailor treatments more effectively to each patient's specific type of disease.
Currently, doctors treat these kidney diseases using the same general approach, but many patients don't respond well to standard treatments and go on to develop kidney failure. By studying the biological differences between patients with similar-looking kidney disease, researchers hope to understand why some people respond to treatment and others don't—and eventually develop better, more personalized treatment strategies.
You likely qualify if…
You likely don't qualify if…
Participation involves periodic visits to a study center where you will have blood samples taken and provide urine samples. If you are in the main study group, you will have a kidney biopsy as part of your standard medical care, and researchers will study that tissue sample. If you are under 19 and in the pediatric group, you may participate without a biopsy. Throughout the study, researchers will collect information about your medical history, your response to treatment, and how your kidney disease progresses over time. The study will follow participants over an extended period to track changes in kidney function and disease activity.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States